8
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Chemotherapeutic Targeting of Etoposide to Regions of the Brain on the Basis of Polyamine Level

, , , &
Pages 457-461 | Published online: 30 Sep 2008

  • Bakic, M., Chan, D., Freireich, E.J., Marton, L.J. and Zwelling, L.A. (1983) "Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase ll-mediated DNA cleavage and cytotoxicity in human and cytotoxicity of 1-ß-D-arabinofuranosylcytosine in 9L rat brain tumor cells pretreated with a-difluoromethylomithine in vitro". Cancer Res. 43, 2541-2544.
  • Bartholeyns, J. and Weser, J.K. (1981) "Effects of a-difluoromethylomithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice. EMT6 solid tumors in mice and solid tumors induced by injection of hepatoma tissue culture cells in rats". Cancer Res. 41, 5158-5161.
  • Busca, A., Miniero, R., Besenzon, L., Cordero-di-Montezemolo, L., Cenni, M., Fagioli, F., Sandri, A., Vassallo, E., Ricardi, U. and Madon, E. (1997) "Etoposide-containing regimens with autologous bone marrow transplantation in children with malignant brain tumors". Child's Nerv. Syst. 13, 572-577.
  • Cipolla, B., Blanchard, Y., Chamaillard, L., Quemener, V., Guille, F., Havouis, R. and Moulinoux, J.P. (1996) "In vivo, synergestic inhibition of MAT-LyLU rat prostatic adenocarcinoma growth by polyamine deprivation and low-dose cyclophosphamide". Urol. Res. 24, 93-98.
  • Desiderio, M.A., Bergamaschi, D., Feudis, P.D., Erba, E. and lncalci. M.D. (1997) "Treatment with inhibitors of polyamine biosynthesis, which selectively lower intracellular spermine. does not affect the activity of alkylating agents but antagonizes the cytotoxicity of DNA topoisomerase Il inhibitors". Br. J. Res. Can. 75, 1028-1034.
  • Emestus, R.I., Rohn, G., Hossomann, K.A. and Paschen, W. (1993) "Polyamine metabolism in experimental brain tumors of rat". J. Neurochem. 60, 417-422.
  • Feuerstein, B.C., Williams, L.D., Basu, H.S. and Manon, L.J. (1991) "Implications and concepts of polyamine-nucleic acid interactions". J. Cell. Biochem. 46, 37-47.
  • Finn, G.P., Bozek, T. Souhami, R.L., Slevin, M.L. and Thomas, D.G. (1985) "High-dose etoposide in the treatment of relapsed primary brain tumors". Cancer Treat. Rep. 69, 603-605.
  • Fredlund, J.O., Johansson, M., Baldetorp, B. and Oredssen, S.M. (1994) "Abnormal DNA synthesis in polyamine deficient cells as revealed by bromodeoxyuridine-flow cytometry technique". Cell Prolif. 249, 243-356.
  • Heby, O., Manon, L.J., Wilson, C.B. and Martinez, H.M. (1975) "Polyamine metabolism in a rat brain tumor cell line: its relationship to the growth rate". J. Cell Physiol. 86, 511-521.
  • Hougaard, D.M. (1992) "Polyamine cytochemistry: localization and possible functions of polyamine". Int. Rev. Cytol. 138, 51-81.
  • Kobrinsky, N.L., Packer, R.J., Boyett, J.M., Stanley, P., Shiminski-Maher. T. Allen, J.C., Garvin, J.H., Stewan, D.J. and Finlay, J.L. (1999) "Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group study. CCG-9881". J Neurooncol. 45, 47-54.
  • Lindsay, G.S. and Wallace, H.M. (1999) "Changes in polyamine catabolism in HL-60 human promyelogenous leukaemic cells in response to etoposide-induced apoptosis". Biochem. J. 337, 83-87.
  • Manon, L.J. and Pegg, A.E. (1995) "Polyamines as targets for therapeutic intervention". Annu. Rev. Pharmacol. Toxicol. 35, 55-91.
  • Needle, M.N., Molloy, P.T., Geyer, J.R., Herman-Liu, A., Belasco, J.B., Goldwein, J.W., Sutton, L. and Phillips, P.C. (1997) "Phase Il study of daily oral etoposide in children with recurrent brain tumors and other solid tumors". Med. Pediatr. Oncol. 29, 28-32.
  • Papadopoulos, K.P., Balmaceda, C., Fetell, M., Kaufman, E., Vahda, L.T., Bruce, J., Sisti, M., lsaacson, S., De-LaPaz, R., Savage, D.G., Troxel, A., Amman, K.H. and Hesdorffer, C.S. (1999) "A phase I study of high-dose BCNU. etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors". J. Neurooncol. 44, 155-162.
  • Pegg, A.E. (1988) "Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy". Cancer Res. 48. 759-774.
  • Porter, C.W., Ganis, B., Libby, P.R. and Bergenron, R.J. (1991) "Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines". Cancer Res. 51, 3715-3720.
  • Quemener, V., Moulinoux, J.P. Havouis, R. and Seiler, N. (1992) "Polyamine deprivation enhances antitumoral efficacy of chemotherapy". Anticancer Res. 12, 1447-1454.
  • Quemener, V., Blanchard, Y. Chamaillard, L., Havouis, R., Cipolla, B. and Moulinoux, J.P (1994) "Polyamine deprivation: a new tool in cancer treatment". Anticancer Res. 14, 443-448.
  • Roelcke, U. (1994) "PET: Brain tumor biochemistry". J. Neurooncol. 22. 275-279.
  • Seiler, N. and Knodgen, B. (1980) "High-performance liquid Chromatographie procedure for the simultaneous determination of the natural polyamines and their monoacetyl derivatives". J. Chromatogr. 221, 227-236.
  • Sunkara, P.S., Fowler, S.K. and Nishioka, K. (1980) "Inhibition of polyamine biosynthesis by a-difluoromethyl omithine potentiates the cytotoxic effects of arabinosyl cytosine in HeIa cells". Biochem. Biophys. Res. Commun. 95, 423-430.
  • Sunkara, P.S., Fowler, S.K. and Nishioka, K. (1981) "Selective killing of transformed cells in combination with inhibitors of polyamine biosynthesis and s-phase specific drugs". Cell Biol. Int. Rep. 5. 991-997.
  • Tfayli, A., Hentschel, P. Madajewicz, S., Manzione, J., Chowhan, N., Davis, R., Roche, P. Iliya, A., Roque, C., Meek, A. and Shady, M. (1999) "Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors". J. Neurooncol. 42, 73-77.
  • Watanabe, S., Sato, S., Nagase, S. and Saito, T. (1992a) "A novel note on the effect of ara-C on the polyamine content of the male accessory organs of the rat". Biochem. Pharmacol. 44, 593-596.
  • Watanabe, S., Sato, S., Nagase, S., Tomita, M., Saito, T. and Ishizu, H. (1992b) "Automated quantitation of polyamines by improved cationexchange high-performance liquid chromatography using a pump equipped with a plunger washing system". J. Liquid Chromatogr. 16, 619-632.
  • Watanabe, S., Sato, S., Nagase, S. and Saito, T. (1993) "Polyamine increase in rats tissues treated with Ara-C and 5-FU". Anti-Cancer Drugs 4, 345-350.
  • Watanabe, S., Sato, S., Nagase, S. and Saito, T. (1996) "Therapeutic significance of the polyamine level in tissues of rats treated with adriamycin and cisplatin". Anti-Cancer Drugs 7, 114-120.
  • Watanabe, S., Sato, S., Nagase, S., Shimosato, K. and Ohkuma, S. (1999a) "Effects of methotrexate and cyclophosphamide on polyamine levels in various tissues of rats". J. Drug Targeting 7, 197-205.
  • Watanabe, S., Sato, S., Nagase, S., Shimosato, K. and Ohkuma, S. (1999b) "Choice of vincristine and 6-mercaptopurine on the basis of polyamine levels in tumor-bearing regions of the brain". Cancer Lett. 139, 51-58.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.